PRAX

Praxis Precision Medicines, Inc.

Latest Form 4:Sale$3.6MbyDeSimone Jill (Director) · filed Jun 26, 2026

Praxis Precision Medicines, Inc. (PRAX) has 36 SEC Form 4 filings (84 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 8, 2026.

Insiders have net sold $3.6M over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Marcio Silva De'Souza
  • Employees:168
  • HQ:Boston, MA, US
  • IPO:2020-10-16

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$44.3M

reported sales (SEC code S)

Unique Insiders

4

in the rolling window

Market Cap

$10.3B

latest known value

Source
DeSimone JillFirst filing
Sale$3.6MJun 26SEC ↗
Mastrocola LaurenFirst filing
Sale$2.6MNov 21SEC ↗
Nemiroff AlexFirst filing
Sale$4.9MNov 21SEC ↗
Sale$33.2MOct 17SEC ↗

Related companies

Praxis Precision Medicines, Inc. is in the Healthcare sector.